Studies have found a significant correlation between MCP-1 gene polymorphisms and AD risk, and MCP-1 plays a crucial regulatory role in neuroinflammation, Aβ deposition, and tau phosphorylation (Table 1). Here, MAPT is linked to Alzheimer disease.